Our successful ClinicalResearch Associates possess varied backgrounds in medical and other science-related healthcare... your in-house and field-based training you may also participate in other clinicalresearch departmental core rotations...
Associate will support Research & Development (R&D) document management initiatives by assisting in document migration projects... better – join our team today! Position Description: The Associate is a member of the Document Management team and is responsible for the...
Job Description Senior ClinicalResearchAssociate: The role is accountable for performance and compliance... of a clinicalresearch study, taking overall responsibility of allocated sites. Actively develops and expands the territory...
Statistical Programming Associate Director Are you an experienced Statistical Programmer with good knowledge... of clinical drug development? Would you like to be part of a fast-paced and agile global team that has direct strategic impact...
lives. Read more: . PHASE IV Associate Global Trial Manager Division-Research and Development Functional Area... operational aspects of complex, global clinicalresearch studies from concept to final clinical study report. Position Summary...
and not a privilege. Research & Development In R&D, we're full of highly skilled talents that include Scientists, Engineers, Medical..., Clinical and Regulatory professionals - all working to create a cleaner, healthier world. With nine Centres of Excellence...
and in discovery pharmacology, forensics, advanced material sciences and agroscience contract research services. It... is also one of the market leaders in certain testing and laboratory services for genomics, and in the support of clinical studies...
of the Publication Planning Associate for VEO is to project manage publications from value, evidence and outcomes (VEO...) projects, provide oversight, and provide subject matter expertise, as needed. The Publication Planning Associate manages VEO...
We are looking for an Associate Content Editor/Content Editor to join our highly regarded Deals team at Chennai, India... for conducting business intelligence research & analysis on public, biotech and pharma companies plus universities related to drug...
Company Name: VARITE India Private Limited About The Client: An American technological research and consulting firm... based in Stamford, Connecticut that conducts research on technology and shares this research through private consulting...
The Ceigall India IPO plans to raise ₹617.69 crore from a fresh issue. The company is going to issue a total of 1.428 crore equity shares for a face value of ₹5 per share. The company filed its draft prospectus with SEBI on March 3, 2024. Continue Reading »
Motilal Oswal report highlighted that the Nifty Microcap 250 and Nifty Smallcap 250 indexes were the top performers, achieving remarkable monthly growth of 11.56% and 7.90%, respectively. Continue Reading »
By 12:30 GMT, Brent crude futures had fallen 42 cents, or 0.5%, to $86.12 a barrel. U.S. West Texas Intermediate (WTI) crude dropped 52 cents, or 0.63%, to $82.64 a barrel. Continue Reading »
According to the draft papers, the IPO comprises a fresh issue of equity shares worth ₹500 crore and an offer for sale (OFS) of up to ₹1,700 crore by promoters and investor shareholders. Continue Reading »
Wall Street: At 9:48 a.m. ET, the Dow Jones was up 0.70 per cent, the S&P 500 was higher 0.24 per cent, the Nasdaq added 0.12 per cent Continue Reading »
Chandan Taparia has recommended three stocks to buy tomorrow, July 9. According to him, these stocks – BHEL, Chambal Fertilizers, GAIL– are technically placed to see a decent upmove. Continue Reading »
The National Stock Exchange last week imposed a price control cap of 90% over the issue price for SME IPOs. The rule means that the listing-day gain can't be more than 90% of the issue price. Some industry experts believe it will discourage speculation, while others worry it could hurt valuations. Continue Reading »
In an exchange filing, the company announced that its board has approved an interim dividend of ₹2.75 per share with a face value of ₹1 each for the financial year 2024-25. Continue Reading »